MOREADITH RANDALL (Chief Scientific Officer) sold 1.70K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/16/2025ACC: 0001301120-25-000033
Officer· Chief Scientific Officer
Since Feb 2026
-1.70K
Net shares
Net seller
$5.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.70K acquired · 3.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.70K
Price / share
$0.06
Trade value
$102.00
% of position
New position
12/12/2025
0.00→1.70K
Common Stock
Direct
Shares
−1.70K
Price / share
$3.26
Trade value
$5.54K
% of position
New position
12/12/2025
1.70K→0.00
Total
Net shares
+0.00
Net value
-$5.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | M · Option Exercise | +1.70K | $0.06 | $102.00 | New position | 0.00 | 1.70K |
| Common Stock Direct | 12/12/2025 | S · Sale | −1.70K | $3.26 | $5.54K | New position | 1.70K | 0.00 |
| Total | +0.00 | -$5.44K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.70K shares
Shares
−1.70K
Strike price
0.06
Held after
365.19K
Exercisable
—
12/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.70K shares | 12/12/2025 | M · Option Exercise | −1.70K | 0.06 | — | 365.19K |